Computational Model of the HIV-1 Subtype A V3 Loop: Study on the Conformational Mobility for Structure-Based Anti-AIDS Drug Design

Abstract The V3 loop of the HIV-1gp120 glycoprotein presenting 35-residue-long, frequently glycosylated, highly variable, and disulfide bonded structure plays the central role in the virus biology and forms the principal target for neutralizing antibodies and the major viral determinant for co-receptor binding. Here we present the computer-aided studies on the 3D structure of the HIV-1 subtype A V3 loop (SA-V3 loop) in which its structurally inflexible regions and individual amino acids were identified and the structure-function analysis of V3 aimed at the informational support for anti-AIDS drug researches was put into practice. To this end, the following successive steps were carried out: (i) using the methods of comparative modeling and simulated annealing, the ensemble of the low-energy structures was generated for the consensus amino acid sequence of the SA-V3 loop and its most probable conformation was defined basing on the general criteria widely adopted as a measure of the quality of protein structures in terms of their 3D folds and local geometry; (ii) the elements of secondary V3 structures in the built conformations were characterized and careful analysis of the corresponding data arising from experimental observations for the V3 loops in various HIV-1 strains was made; (iii) to reveal common structural motifs in the HIV-1 V3 loops regardless of their sequence variability and medium inconstancy, the simulated structures were collated with each other as well as with those of V3 deciphered by NMR spectroscopy and X-ray studies for diverse virus isolates in different environments; (iv) with the object of delving into the conformational features of the SA-V3 loop, molecular dynamics trajectory was computed from its static 3D structure followed by determining the structurally rigid V3 segments and comparing the findings obtained with the ones derived hereinbefore; and (v) to evaluate the masking effect that can occur due to interaction of the SA-V3 loop with the two virtual molecules constructed previously by tools of computational modeling and named FKBP and CycA peptides, molecular docking of V3 with these molecules was implemented and inter-atomic contacts appearing in the simulated complexes were analyzed to specify the V3 stretches keeping in touch with the ligands. As a matter of record, V3 segments 3–7, 15–20, and 28–32 containing the highly conserved and biologically meaningful residues of gp120 were shown to retain their 3D main chain shapes in all the cases of interest presenting the forward-looking targets for anti-AIDS drug researches. From the data on molecular docking, synthetic analogs of the CycA and FKBP peptides were suggested being suitable frameworks for making a reality of the V3-based anti-HIV-1 drug projects.

[1]  R F Standaert,et al.  Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex , 1991, Science.

[2]  Pengyu Y. Ren,et al.  Polarizable Atomic Multipole Water Model for Molecular Mechanics Simulation , 2003 .

[3]  Michael M. Endrich,et al.  The V3 loop of human immunodeficiency virus type-1 envelope protein is a high-affinity ligand for immunophilins present in human blood. , 1998, European journal of biochemistry.

[4]  J. Davide,et al.  Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. , 1990, Science.

[5]  A. Andrianov Study on conformational homology of the HIV-1 gp120 protein V3 loop. Structural analysis of the HIV-RF and HIV-thailand viral strains , 2007 .

[6]  A. Andrianov,et al.  Immunophilins and HIV-1 V3 Loop For Structure-Based Anti-AIDS Drug Design , 2009, Journal of biomolecular structure & dynamics.

[7]  D. van der Spoel,et al.  GROMACS: A message-passing parallel molecular dynamics implementation , 1995 .

[8]  Oliver Hartley,et al.  V3: HIV's switch-hitter. , 2005, AIDS research and human retroviruses.

[9]  A. Andrianov Computational Anti-AIDS Drug Design Based on the Analysis of the Specific Interactions Between Immunophilins and the HIV-1 gp120 V3 Loop. Application to the FK506-Binding Protein , 2008, Journal of biomolecular structure & dynamics.

[10]  Stephen Taylor,et al.  Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization. , 2005, Journal of molecular biology.

[11]  K. Chou,et al.  Glycosylation of HIV-1 gp120 V3 loop: towards the rational design of a synthetic carbohydrate vaccine. , 2007, Current medicinal chemistry.

[12]  Reed J. Harris,et al.  Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. , 1990, The Journal of biological chemistry.

[13]  H. Berendsen,et al.  Interaction Models for Water in Relation to Protein Hydration , 1981 .

[14]  Structure and Polymorphism of the Principal Neutralization Site of Thailand HIV-1 Isolate , 2003, Journal of biomolecular structure & dynamics.

[15]  K. Kopple,et al.  Reverse Turns in Peptides and Protein , 1980 .

[16]  Adeeba Kamarulzaman,et al.  AIDS Res Hum Retroviruses , 2006 .

[17]  David Yang,et al.  The N-Terminal V3 Loop Glycan Modulates the Interaction of Clade A and B Human Immunodeficiency Virus Type 1 Envelopes with CD4 and Chemokine Receptors , 2000, Journal of Virology.

[18]  H. Dyson,et al.  Solution conformational preferences of immunogenic peptides derived from the principal neutralizing determinant of the HIV-1 envelope glycoprotein gp120. , 1991, Biochemistry.

[19]  Kuo-Chen Chou,et al.  HIV-1 gp120 V3 loop for structure-based drug design. , 2005, Current protein & peptide science.

[20]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.

[21]  Roland L. Dunbrack,et al.  Backbone-dependent rotamer library for proteins. Application to side-chain prediction. , 1993, Journal of molecular biology.

[22]  P. Auewarakul,et al.  N-linked glycosylation in C2 region of HIV-1 envelope reduces sensitivity to neutralizing antibodies. , 2005, Viral immunology.

[23]  V. Veresov,et al.  Determination of structurally conservative amino acids of the HIV-1 protein gp120 V3 loop as promising targets for drug design by protein engineering approaches , 2006, Biochemistry (Moscow).

[24]  J. Morris,et al.  Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain. , 1991, AIDS research and human retroviruses.

[25]  Characteristics of HIV-1 env V3 loop sequences for subtype A1 variant spread in Eastern Europe. , 2005, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[26]  Global and local structural properties of the principal neutralizing determinant of the HIV-1 envelope protein gp120. , 1999, Journal of biomolecular structure & dynamics.

[27]  L. Stamatatos,et al.  N-Linked Glycosylation of the V3 Loop and the Immunologically Silent Face of gp120 Protects Human Immunodeficiency Virus Type 1 SF162 from Neutralization by Anti-gp120 and Anti-gp41 Antibodies , 2004, Journal of Virology.

[28]  I. Wilson,et al.  Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop. , 2003, Virology.

[29]  M. Cho,et al.  N-Linked Glycosylation Sites Adjacent to and within the V1/V2 and the V3 Loops of Dualtropic Human Immunodeficiency Virus Type 1 Isolate DH12 gp120 Affect Coreceptor Usage and Cellular Tropism , 2001, Journal of Virology.

[30]  P. Bisen,et al.  HIV and AIDS:: Basic Elements and Priorities , 2007 .

[31]  J. Riley,et al.  A single point mutation in HIV-1 V3 loop alters the immunogenic properties of rgp120 , 2000, Archives of Virology.

[32]  J M Thornton,et al.  Analysis of main chain torsion angles in proteins: prediction of NMR coupling constants for native and random coil conformations. , 1996, Journal of molecular biology.

[33]  I. Wilson,et al.  Crystal structure of the principal neutralization site of HIV-1. , 1994, Science.

[34]  Peter A. Kollman,et al.  AMBER: Assisted model building with energy refinement. A general program for modeling molecules and their interactions , 1981 .

[35]  Emmanuel G. Cormier,et al.  The Crown and Stem of the V3 Loop Play Distinct Roles in Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Interactions with the CCR5 Coreceptor , 2002, Journal of Virology.

[36]  Jaap Goudsmit,et al.  N-Linked Glycosylation of the HIV Type-1 gp120 Envelope Glycoprotein as a Major Determinant of CCR5 and CXCR4 Coreceptor Utilization* , 2001, The Journal of Biological Chemistry.

[37]  B. Meyer,et al.  Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1. , 2001, Glycobiology.

[38]  S. Zolla-Pazner,et al.  A Highly Conserved Arginine in gp120 Governs HIV-1 Binding to Both Syndecans and CCR5 via Sulfated Motifs* , 2005, Journal of Biological Chemistry.

[39]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[40]  K. Chou,et al.  Simulated annealing approach to the study of protein structures. , 1991, Protein engineering.

[41]  David W Ritchie,et al.  Docking essential dynamics eigenstructures , 2005, Proteins.

[42]  A. Andrianov,et al.  Method of determining protein conformations by the two-dimensional nuclear Overhauser enhancement spectroscopy data. , 1987, Journal of biomolecular structure & dynamics.

[43]  Chris Oostenbrink,et al.  A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force‐field parameter sets 53A5 and 53A6 , 2004, J. Comput. Chem..

[44]  P. Taylor,et al.  X-Ray Structures and Analysis of 11 Cyclosporin Derivatives Complexed with Cyclophilin A. , 1998 .

[45]  J. Goudsmit,et al.  Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution , 1992, Journal of virology.

[46]  Local Structural Properties of the V3 Loop of Thailand HIV-1 Isolate , 2002, Journal of biomolecular structure & dynamics.

[47]  A. Andrianov Dual Spatial Folds and Different Local Structures of the HIV-1 Immunogenic Crown in Various Virus Isolates , 2004, Journal of biomolecular structure & dynamics.

[48]  A. Andrianov Determining the Invariant Structure Elements of the HIV-1 Variable V3 Loops: Insight into the HIV-MN and HIV-Haiti Isolates , 2008, Journal of biomolecular structure & dynamics.

[49]  H. Scheraga,et al.  Chain reversals in proteins. , 1973, Biochimica et biophysica acta.

[50]  A. Sali,et al.  Modeling of loops in protein structures , 2000, Protein science : a publication of the Protein Society.

[51]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[52]  3D Structure Model of the Principal Neutralizing Epitope of Minnesota HIV-1 Isolate , 2004, Journal of biomolecular structure & dynamics.

[53]  Bette Korber,et al.  Structure of a V3-Containing HIV-1 gp120 Core , 2005, Science.

[54]  M. Rey-Cuillé,et al.  N-linked glycosylation in the V3 region of HIV type 1 surface antigen modulates coreceptor usage in viral infection. , 2001, AIDS research and human retroviruses.

[55]  R L Stanfield,et al.  Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[56]  M. Essex,et al.  CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[57]  S. Sherman,et al.  Derivation of locally accurate spatial protein structure from NMR data. , 1993, Progress in biophysics and molecular biology.

[58]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[59]  V. Veresov,et al.  Structural Analysis of the HIV-1 gp120 V3 Loop: Application to the HIV-Haiti Isolates , 2007, Journal of biomolecular structure & dynamics.

[60]  H. Schuitemaker,et al.  Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule , 1992, Journal of virology.